Study of ADCs Combined With Adebrelimab in HER2-negative Advanced Breast Cancer
Study of ADCs Combined With Adebrelimab in HER2-negative Advanced Breast Cancer
Recruiting · NCT06433609 · Registry updated 2026-07-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of ADCs Combined With Adebrelimab in HER2-negative Advanced Breast Cancer | Advanced Breast Cancer | Recruiting | Phase 2 | 2026-07-14 | NCT06433609 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing GoBroad Hospital | 42 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing GoBroad Hospital | Beijing | China | 14 |